Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibiayi Dagogo-Jack

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 25, 2023
We Don't Talk (Enough) About BRAFIbiayi Dagogo-Jack
JAMA Oncology|September 2, 2021
Inserting Ensartinib Into the Starting Lineup for ALK-Rearranged Lung Cancer-A Likely Limited Role on a Deep BenchIbiayi Dagogo-Jack
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|May 28, 2011
That which we carry with usIbiayi Dagogo-Jack
JCO Precision Oncology|November 22, 2023
Targeted Approaches to Treatment of Pleural Mesothelioma: A ReviewIbiayi Dagogo-Jack
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2020
Durable Response to Dabrafenib Combined With Trametinib in a Patient With NSCLC Harboring a BRAF G469A MutationIbiayi Dagogo-Jack
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2026
Reply to the Letter to the Editor From Lee et alIbiayi Dagogo-Jack
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2022
There Is No Unmet Need for Another Programmed Cell Death Protein-1 or Programmed Death-Ligand 1 Inhibitor for Metastatic NSCLCIbiayi Dagogo-Jack, Zofia Piotrowska
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2020
Reply to the Letter to the Editor From Zhou et alIbiayi Dagogo-Jack, Mari Mino-Kenudson
The Oncologist|June 2, 2016
Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?Ibiayi Dagogo-Jack, Alice T Shaw
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2017
Expanding the Roster of ROS1 InhibitorsIbiayi Dagogo-Jack, Alice T Shaw
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 25, 2023
We Don't Talk (Enough) About BRAFIbiayi Dagogo-Jack
JAMA Oncology|September 2, 2021
Inserting Ensartinib Into the Starting Lineup for ALK-Rearranged Lung Cancer-A Likely Limited Role on a Deep BenchIbiayi Dagogo-Jack
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|May 28, 2011
That which we carry with usIbiayi Dagogo-Jack
JCO Precision Oncology|November 22, 2023
Targeted Approaches to Treatment of Pleural Mesothelioma: A ReviewIbiayi Dagogo-Jack
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2020
Durable Response to Dabrafenib Combined With Trametinib in a Patient With NSCLC Harboring a BRAF G469A MutationIbiayi Dagogo-Jack
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2026
Reply to the Letter to the Editor From Lee et alIbiayi Dagogo-Jack
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2022
There Is No Unmet Need for Another Programmed Cell Death Protein-1 or Programmed Death-Ligand 1 Inhibitor for Metastatic NSCLCIbiayi Dagogo-Jack, Zofia Piotrowska
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2020
Reply to the Letter to the Editor From Zhou et alIbiayi Dagogo-Jack, Mari Mino-Kenudson
The Oncologist|June 2, 2016
Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?Ibiayi Dagogo-Jack, Alice T Shaw
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2017
Expanding the Roster of ROS1 InhibitorsIbiayi Dagogo-Jack, Alice T Shaw
Pageof 10